Estrella Immunopharma Inc. (ESLA)
NASDAQ
Real-time Data
01:30 PM
Day's Range
0.720152 wk Range
0.6780Overview - ESLA - Estrella Immunopharma Inc.
Key Statistics
Valuation
Enterprise Value
31.83M
P/E (Trailing)
‪-2.14‬
P/E (Forward)
‪-2.31‬
PEG Ratio
‪0.12‬
Price / Book
‪-5.99‬
EV / EBITDA
‪-2.43‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-251.86%‬
Return on Equity
‪126.02%‬
Ownership
Shares Outstanding
42.66M
Float
14.57M
Short % of Shares Outstanding
‪0.28%‬
Held by Insiders
‪59.96%‬
Held by Institutions
‪11.13%‬
Price stats
Beta
‪0.88‬
50-Day Avg
‪0.8475‬
200-Day Avg
‪1.28‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - ESLA - Estrella Immunopharma Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ESLANASDAQEstrella Immunopharma Inc.31.97MMarket Cap-31.84%52-week change-2.14P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt62.93BMarket Cap+33.08%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.58BMarket Cap-87.93%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+23.98%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.84BMarket Cap+39.72%52-week change-21.44P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ESLA - Estrella Immunopharma Inc.
About
Estrella Immunopharma Inc. is a biotechnology company dedicated to the research and development of innovative therapies. Primarily focusing on creating advanced treatment options for cancer and other serious diseases, the company harnesses cutting-edge technologies to address unmet medical needs. Estrella Immunopharma…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
